Overview

Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction

Status:
COMPLETED
Trial end date:
2024-05-10
Target enrollment:
Participant gender:
Summary
Polycystic Ovarian Syndrome (PCOS) is the most common endocrine disorders in women of reproductive age. According to the World Health Organization (WHO) estimation revealed over 116 million women (3.4%) are affected by PCOS worldwide. Owing to the intricacy of this condition, various sets of diagnostic criteria have been initiated for the confirmation of PCOS which are: National Institute of Health, Rotterdam's Criteria, Androgen Excess and PCOS society. The prevalence of PCOS is estimated at about 4 to 21 % when it is diagnosed according to the Rotterdam criteria accounting for 75% of cases with anovulatory infertility.
Phase:
NA
Details
Lead Sponsor:
Al-Azhar University
Treatments:
Cabergoline
Letrozole